After a nine-month investigation into direct-to-consumer telehealth platforms launched by Eli Lilly and Pfizer, a group of ...

In today's digital age, brands are facing increasing pressure to be transparent. Recent incidents, like the Air India crash ...

Key Points President Trump has threatened to levy tariffs of up to 200% on pharmaceutical imports.Lilly's margins could be negatively affected if the company absorbs the higher costs.However, any ...

Eli Lilly (LLY) announces detailed data from a Phase 3 trial that tested its oral weight loss drug orforglipron in those with type 2 diabetes. Read more here.

Meanwhile, Lilly is notching win after win. Eli Lilly's position in the weight management market makes its stock attractive, considering how fast this area is projected to grow in the coming years.

Shares of Eli Lilly & Co. LLY slid 2.47% to $775.45 Friday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index SPX rising 0.52% to 6,173.07 ...

This lawsuit may look like a business dispute on the surface. But underneath, it’s about something much more important: the right of patients to receive personalized, affordable care.

Patients who took an experimental drug from Eli Lilly & Co. together with Novo Nordisk A/S’s Wegovy maintained muscle while losing weight, offering a potential solution to one of the key ...

In France, for example, Tesla will now be fined for every day it continues its "deceptive marketing practices," Politico reports.

The Department of Justice launched an investigation into the University of California and its campuses, saying there are concerns about potential race and sex-based discrimination in the UC's ...

Novo Nordisk said it will stop selling Wegovy on Hims & Hers, claiming the telehealth company sold knockoff versions of the weight-loss drug.

Researchers surveyed senior marketers to learn about how they use marketing technology. They determined that the systems have modest impact, they’re not achieving their expected performance ...